MedPath

Comparison of the effect of botanical extract mouthwashes of meswak/aloe vera and chlorhexidine on prevention of ventilator-associated pneumonia

Phase 3
Conditions
Ventilator-associated pneumonia.
Registration Number
IRCT20161014030294N4
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Existence of endotracheal tube through the mouth
Age 16 to 65 years
Mechanical ventilation for at least 72 hours
Absence of lung infection based on the clinical score of the modified lung infection
Lack of sensitivity to plant compounds
Absence of sepsis
Absence of pulmonary thromboembolism
Absence of atelectasis
Absence of inflammatory diseases of the gastrointestinal tract
Absence of severe liver and bile duct diseases

Exclusion Criteria

Transfer the patient from the ICU or die before completing the study
Reluctance of the patient's companions to continue the study
Observe the side effects of using mouthwash such as hives, itching and skin rashes
Sudden changes in the patient's clinical condition or respiratory pattern occur
Existence of defects in the patient's immune system

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The rate of ventilator-induced pneumonia. Timepoint: 72 hours and 7 days after the intervention and when the patient is extubated. Method of measurement: Microbiological tests of lung secretions.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath